JUBLINGREA

Jubilant Ingrevia Limited

Specialty chemicals, nutrition products and chemical intermediates manufacturer

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

jubilantingrevia.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹630.95
Market cap
10,050 Cr
Stock P/E
32.6
P/B
3.21
Dividend yield
0.8%
ROE (FY26)
8.9%
ROCE (FY26)
10.7%
Operating margin (FY26)
8.9%
Debt / equity (FY26)
0.25
OCF / EBITDA (FY26)
92.5%
OCF / EBITDA (3Y)
97.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Jubilant Ingrevia makes specialty chemicals, nutrition ingredients and acetyl-based chemical intermediates, including custom development and manufacturing for pharma and agro customers.

Company snapshot

15thBy market cap

Ranked among 68 companies in Specialty Chemicals.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 48.3% of revenue

SegmentRevenue shareRevenuePBTAssets
Chemicals Intermediates
39.8%
1,243 Cr61 Cr—
Nutrition and Health Solutions
17.9%
558 Cr62 Cr—
Speciality Chemicals
48.3%
1,509 Cr223 Cr—

Shares add up to 106% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓97% of operating profit came in as cash over the last three years — profits are backed by real cash.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,020 Cr966 Cr1,074 Cr1,024 Cr1,045 Cr1,057 Cr1,051 Cr1,038 Cr1,121 Cr1,051 Cr1,179 Cr1,300 Cr
Operating expenses (approx.)902 Cr871 Cr983 Cr915 Cr921 Cr918 Cr905 Cr896 Cr985 Cr924 Cr1,016 Cr1,101 Cr
EBITDA118 Cr96 Cr91 Cr110 Cr125 Cr138 Cr147 Cr142 Cr136 Cr127 Cr163 Cr199 Cr
OPM %11.5%9.9%8.5%10.7%11.9%13.1%14.0%13.7%12.1%12.0%13.8%15.3%
Other income9 Cr9 Cr10 Cr10 Cr10 Cr9 Cr8 Cr11 Cr11 Cr9 Cr9 Cr10 Cr
Interest13 Cr15 Cr14 Cr14 Cr15 Cr12 Cr14 Cr13 Cr12 Cr12 Cr12 Cr17 Cr
Depreciation34 Cr34 Cr36 Cr39 Cr40 Cr40 Cr39 Cr41 Cr41 Cr45 Cr48 Cr51 Cr
Profit before tax80 Cr55 Cr51 Cr66 Cr80 Cr96 Cr102 Cr100 Cr93 Cr65 Cr112 Cr141 Cr
Tax %28.0%30.0%43.0%26.2%26.5%27.4%27.2%24.7%25.2%28.3%22.6%24.9%
Net profit57 Cr39 Cr29 Cr49 Cr59 Cr69 Cr74 Cr75 Cr69 Cr47 Cr86 Cr106 Cr
EPS (₹)₹3.64₹2.44₹1.85₹3.08₹3.73₹4.39₹4.69₹4.75₹4.40₹2.97₹5.47₹6.70

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales684 Cr4,949 Cr4,773 Cr4,136 Cr4,178 Cr4,388 CrSign in free for the trailing twelve months
Operating expenses (approx.)567 Cr4,118 Cr4,226 Cr3,715 Cr3,659 Cr3,821 CrSign in free for the trailing twelve months
EBITDA117 Cr832 Cr547 Cr421 Cr519 Cr567 CrSign in free for the trailing twelve months
OPM %17.1%16.8%11.5%10.2%12.4%12.9%Sign in free for the trailing twelve months
Other income3 Cr31 Cr33 Cr35 Cr38 Cr41 CrSign in free for the trailing twelve months
Interest7 Cr31 Cr22 Cr53 Cr56 Cr49 CrSign in free for the trailing twelve months
Depreciation22 Cr123 Cr122 Cr136 Cr158 Cr175 CrSign in free for the trailing twelve months
Profit before tax77 Cr709 Cr437 Cr268 Cr344 Cr370 CrSign in free for the trailing twelve months
Tax %29.8%32.8%29.6%31.7%26.9%24.8%Sign in free for the trailing twelve months
Net profit54 Cr477 Cr308 Cr183 Cr251 Cr278 CrSign in free for the trailing twelve months
EPS (₹)₹20.78₹29.98₹19.34₹11.56₹15.89₹17.59Sign in free for the trailing twelve months
Dividend payout %0.0%9.5%25.8%43.0%31.8%28.5%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital16 Cr16 Cr16 Cr16 Cr16 Cr16 Cr
Reserves1,907 Cr2,417 Cr2,650 Cr2,722 Cr2,911 Cr3,110 Cr
Borrowings456 Cr229 Cr397 Cr733 Cr764 Cr792 Cr
Other liabilities1,000 Cr1,135 Cr1,196 Cr1,261 Cr1,341 Cr1,566 Cr
Total liabilities3,379 Cr3,797 Cr4,259 Cr4,732 Cr5,032 Cr5,484 Cr
Fixed assets (net)1,745 Cr1,745 Cr1,788 Cr2,478 Cr2,558 Cr3,148 Cr
CWIP63 Cr169 Cr525 Cr331 Cr525 Cr154 Cr
Investments48 Cr6 Cr8 Cr16 Cr37 Cr33 Cr
Loans & advances2 Cr0.45 Cr0.53 Cr0.43 Cr0.32 Cr0.43 Cr
Inventories609 Cr911 Cr1,035 Cr941 Cr943 Cr880 Cr
Trade receivables471 Cr581 Cr511 Cr572 Cr607 Cr783 Cr
Cash & bank73 Cr38 Cr73 Cr79 Cr69 Cr188 Cr
Other assets367 Cr346 Cr319 Cr316 Cr292 Cr297 Cr
Total assets3,379 Cr3,797 Cr4,259 Cr4,732 Cr5,032 Cr5,484 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity112 Cr453 Cr462 Cr430 Cr508 Cr524 Cr
Cash from investing-44 Cr-72 Cr-472 Cr-569 Cr-393 Cr-276 Cr
Cash from financing-72 Cr-418 Cr42 Cr144 Cr-129 Cr-155 Cr
Net cash flow-4 Cr-36 Cr35 Cr6 Cr-9 Cr119 Cr
Free cash flow (OCF − Capex)85 Cr223 Cr-19 Cr-138 Cr142 Cr225 Cr

Ratios

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %3.6%27.8%15.0%9.2%10.8%10.7%
ROE %2.8%19.6%11.5%6.7%8.6%8.9%
Debtor days2514339505365
Inventory days610119148168167152
Days payable695104114137145163
Cash conversion cycle1665772827654
OCF / EBITDA %95.9%54.4%84.5%102.1%97.9%92.5%
OCF / EBITDA % (3 years)——68.7%74.7%94.2%97.0%
Debt / equity0.240.090.150.270.260.25
Current ratio1.591.681.541.381.321.29
Net debt / EBITDA3.270.230.591.551.341.06